Colorectal Cancer - FOI Response Register

FoI Number
2023-757
Subject
Colorectal Cancer
Date Received
05/03/2024
Request and Response
  1. In the past 3 months, how many patients have been treated for Colorectal Cancer [CRC] with the following regimens? If possible, please also provide the split of metastatic vs non-metastatic patients for each regimen.

Regimens

Total patients

Capecitabine

 

CAPIRI

 

CAPOX

 

Cetuximab with FOLFIRI

<5

Cetuximab with FOLFOX

 

Cetuximab as a single agent

 

Cetuximab with Encorafenib

 

Irinotecan as a single agent

<5

FOLFIRI

<5

FOLFOX

 

Fluorouracil (5FU) as a single agent

 

Oxaliplatin as a single agent

 

Nivolumab with Ipilimumab

 

Panitumumab with FOLFIRI

 

Panitumumab with FOLFOX

 

Panitumumab as a single agent

 

Pembrolizumab

 

Any other systemic anti-cancer therapy

<5

Palliative care only

 

We have not provided the requested metastatic vs non-metastatic breakdown and have given <5 answers in places. This is because NHS Shetland considers that providing more detailed information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.